Shanghai ZJ Bio-Tech Co. Ltd. A (688317) — Net Asset Quality Index
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a Net Asset Quality Index of 89.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.71 Billion minus total liabilities of CN¥404.13 Million yields net assets of CN¥3.30 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Shanghai ZJ Bio-Tech Co. Ltd. A to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai ZJ Bio-Tech Co. Ltd. A Net Asset Quality Index Over Time (2013–2025)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 89.1%, representing net assets of CN¥3.30 Billion against total assets of CN¥3.71 Billion CNY. Explore how efficiently does Shanghai ZJ Bio-Tech Co. Ltd. A generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shanghai ZJ Bio-Tech Co. Ltd. A (688317) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.0% | CN¥3.35 Billion | CN¥3.76 Billion | CN¥414.95 Million | ▼ -7.0 pp |
| 2024 | 96.0% | CN¥3.64 Billion | CN¥3.79 Billion | CN¥153.06 Million | ▲ +2.1 pp |
| 2023 | 93.9% | CN¥3.82 Billion | CN¥4.07 Billion | CN¥249.25 Million | ▲ +5.3 pp |
| 2022 | 88.5% | CN¥4.20 Billion | CN¥4.74 Billion | CN¥543.44 Million | ▼ -1.4 pp |
| 2021 | 90.0% | CN¥3.83 Billion | CN¥4.25 Billion | CN¥427.27 Million | ▲ +12.1 pp |
| 2020 | 77.8% | CN¥1.46 Billion | CN¥1.88 Billion | CN¥416.97 Million | ▼ -11.3 pp |
| 2019 | 89.1% | CN¥571.84 Million | CN¥641.93 Million | CN¥70.09 Million | ▼ -2.8 pp |
| 2018 | 91.9% | CN¥532.66 Million | CN¥579.64 Million | CN¥46.98 Million | ▲ +0.3 pp |
| 2017 | 91.6% | CN¥472.70 Million | CN¥516.12 Million | CN¥43.42 Million | ▼ -0.3 pp |
| 2016 | 91.9% | CN¥483.90 Million | CN¥526.57 Million | CN¥42.66 Million | ▲ +4.8 pp |
| 2015 | 87.1% | CN¥343.47 Million | CN¥394.29 Million | CN¥50.82 Million | ▲ +31.8 pp |
| 2014 | 55.3% | CN¥110.35 Million | CN¥199.63 Million | CN¥89.28 Million | ▼ -14.2 pp |
| 2013 | 69.5% | CN¥118.03 Million | CN¥169.78 Million | CN¥51.75 Million | — |